SCHEMBL8537819

SCHEMBL8537819

CSc1nc(C)nc(SC)c1NC(=O)Nc1c(-c2ccccc2Cl)c2cc(C(C)C)ccc2n(C)c1=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FPR2 P25090 3/20 0.37
KDM4E B2RXH2 1/20 0.36
TSPO P30536 1/20 0.35
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
ALDH1A1 P00352 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C9 P11712 1/20 0.34
MAPK1 P28482 1/20 0.34
CASP1 P29466 1/20 0.34
CYP2C19 P33261 1/20 0.34
CASP7 P55210 1/20 0.34
NPC1 O15118 1/20 0.34
POLB P06746 1/20 0.34
MAPT P10636 1/20 0.34
RAB9A P51151 1/20 0.34
LMNA P02545 2/20 0.33
WEE1 P30291 2/20 0.33
MAT2A P31153 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8543688 0.90 SOAT1 (0.38) FPR2KDM4ETSPOMEN1KMT2A
SCHEMBL8544183 0.90 POLB (0.37) MEN1KMT2ANPC1POLBMAPT
SCHEMBL8545691 0.90 KDM4E (0.39) FPR2KDM4EMEN1KMT2AALDH1A1
SCHEMBL8542241 0.87 MAPT (0.36) FPR2KDM4EMEN1KMT2ACYP1A2
SCHEMBL9373127 0.84 KDM4E (0.33) KDM4ETSPOMEN1KMT2AALDH1A1
SCHEMBL8539254 0.81 KDM4E (0.35) FPR2KDM4EMAPTLMNA
SCHEMBL8542206 0.81 SOAT1 (0.41) NPC1POLBMAPTRAB9ALMNA
SCHEMBL8538956 0.80 SOAT1 (0.40) KDM4EMEN1KMT2APOLBMAPT
SCHEMBL9359029 0.80 RECQL (0.45) KDM4ENPC1
SCHEMBL8835325 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0623112-B1 4-Phenyl-3-(heteroarylureido)-1,2-dihydro-2-oxoquinoline derivatives as antihypercholesterolemic and antiatherosclerotic agents PFIZER (US) 1998-12-30 EP claimed
JP-2668163-B2 1997-10-27 JP claimed
US-5565472-A 4-aryl-3-(heteroarylureido)-1,2-dihydro-2-oxo-quinoline derivatives as antihypercholesterolemic and antiatherosclerotic agents PFIZER INC. (US) 1996-10-15 US claimed
WO-1993015058-A1 4-ARYL-3-(HETEROARYLUREIDO)-1,2-DIHYDRO-2-OXO-QUINOLINE DERIVATIVES AS ANTIHYPERCHOLESTEROLEMIC AND ANTIATHEROSCLEROTIC AGENTS PFIZER INC. (US) 1993-08-05 WO claimed
EP-0623112-B1 4-Phenyl-3-(heteroarylureido)-1,2-dihydro-2-oxoquinoline derivatives as antihypercholesterolemic and antiatherosclerotic agents PFIZER (US) 1998-12-30 EP disclosed
US-5565472-A 4-aryl-3-(heteroarylureido)-1,2-dihydro-2-oxo-quinoline derivatives as antihypercholesterolemic and antiatherosclerotic agents PFIZER INC. (US) 1996-10-15 US disclosed
WO-1993015058-A1 4-ARYL-3-(HETEROARYLUREIDO)-1,2-DIHYDRO-2-OXO-QUINOLINE DERIVATIVES AS ANTIHYPERCHOLESTEROLEMIC AND ANTIATHEROSCLEROTIC AGENTS PFIZER INC. (US) 1993-08-05 WO disclosed